- Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
-
Reboux PA, Azaïs H, Canova CH, Bendifallah S, Ouldamer L, Raimond E, Hudry D, Coutant C, Graesslin , Touboul C, Collinet P, Bricou A, Huchon C, Daraï E, Ballester , Lévêque , Lavoué V, Koskas M, Uzan C, Canlorbe G
- KMID: 2450232
- J Gynecol Oncol.
- 2019 Jul;30(4):e53.
- doi: 10.3802/jgo.2019.30.e53
OBJECTIVE: According to recent European Society of Medical Oncology, European Society of Gynaecological Oncology and European Society of Radiotherapy and Oncology guidelines, adjuvant vaginal brachytherapy (VB) is optional in patients... -
- CITED
-
- Close
- SHARE
-
- Close
